361 related articles for article (PubMed ID: 8271029)
21. Abnormalities of energy metabolism in Alzheimer's disease studied with PET.
Heiss WD; Szelies B; Kessler J; Herholz K
Ann N Y Acad Sci; 1991; 640():65-71. PubMed ID: 1776760
[TBL] [Abstract][Full Text] [Related]
22. Diminished glucose transport in Alzheimer's disease: dynamic PET studies.
Jagust WJ; Seab JP; Huesman RH; Valk PE; Mathis CA; Reed BR; Coxson PG; Budinger TF
J Cereb Blood Flow Metab; 1991 Mar; 11(2):323-30. PubMed ID: 1997504
[TBL] [Abstract][Full Text] [Related]
23. Regional cerebral glucose transport and utilization in Alzheimer's disease.
Friedland RP; Jagust WJ; Huesman RH; Koss E; Knittel B; Mathis CA; Ober BA; Mazoyer BM; Budinger TF
Neurology; 1989 Nov; 39(11):1427-34. PubMed ID: 2812318
[TBL] [Abstract][Full Text] [Related]
24. Regional difference in cerebral blood flow and oxidative metabolism in human cortex.
Ishii K; Sasaki M; Kitagaki H; Sakamoto S; Yamaji S; Maeda K
J Nucl Med; 1996 Jul; 37(7):1086-8. PubMed ID: 8965174
[TBL] [Abstract][Full Text] [Related]
25. Alzheimer's disease: focal cortical changes shown by positron emission tomography.
Foster NL; Chase TN; Fedio P; Patronas NJ; Brooks RA; Di Chiro G
Neurology; 1983 Aug; 33(8):961-5. PubMed ID: 6603596
[TBL] [Abstract][Full Text] [Related]
26. [Cerebral blood flow, cerebral oxygen metabolism, cerebral glucose metabolism, and tissue pH in human acute cerebral infarction using positron emission tomography].
Kitamura S; Kato A; Yamamoto YL; Hakim AM; Diksic M; Meyer E; Tyler J; Thompson C; Pokrupa R
No To Shinkei; 1985 Jan; 37(1):56-64. PubMed ID: 3872130
[TBL] [Abstract][Full Text] [Related]
27. Glucose metabolism and rate constants in Alzheimer's disease examined with dynamic positron emission tomography scan.
Fukuyama H; Kameyama M; Harada K; Nishizawa S; Senda M; Mukai T; Yonekura Y; Torizuka K
Acta Neurol Scand; 1989 Oct; 80(4):307-13. PubMed ID: 2816287
[TBL] [Abstract][Full Text] [Related]
28. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease.
Minoshima S; Giordani B; Berent S; Frey KA; Foster NL; Kuhl DE
Ann Neurol; 1997 Jul; 42(1):85-94. PubMed ID: 9225689
[TBL] [Abstract][Full Text] [Related]
29. Cerebral mapping of apraxia in Alzheimer's disease by positron emission tomography.
Foster NL; Chase TN; Patronas NJ; Gillespie MM; Fedio P
Ann Neurol; 1986 Feb; 19(2):139-43. PubMed ID: 3485952
[TBL] [Abstract][Full Text] [Related]
30. Alzheimer's disease: anterior-posterior and lateral hemispheric alterations in cortical glucose utilization.
Friedland RP; Budinger TF; Koss E; Ober BA
Neurosci Lett; 1985 Feb; 53(3):235-40. PubMed ID: 3872424
[TBL] [Abstract][Full Text] [Related]
31. Hemodynamic and metabolic effects of cerebral revascularization.
Leblanc R; Tyler JL; Mohr G; Meyer E; Diksic M; Yamamoto L; Taylor L; Gauthier S; Hakim A
J Neurosurg; 1987 Apr; 66(4):529-35. PubMed ID: 3494109
[TBL] [Abstract][Full Text] [Related]
32. Impaired metabolic activation in Alzheimer's disease: a PET study during continuous visual recognition.
Kessler J; Herholz K; Grond M; Heiss WD
Neuropsychologia; 1991; 29(3):229-43. PubMed ID: 2057055
[TBL] [Abstract][Full Text] [Related]
33. Age at onset and regional cerebral glucose metabolism in Alzheimer's disease.
Yasuno F; Imamura T; Hirono N; Ishii K; Sasaki M; Ikejiri Y; Hashimoto M; Shimomura T; Yamashita H; Mori E
Dement Geriatr Cogn Disord; 1998; 9(2):63-7. PubMed ID: 9524795
[TBL] [Abstract][Full Text] [Related]
34. Gender differences in cortical glucose metabolism in Alzheimer's disease and normal aging.
Siegel BV; Shihabuddin L; Buchsbaum MS; Starr A; Haier RJ; Valladares Neto DC
J Neuropsychiatry Clin Neurosci; 1996; 8(2):211-4. PubMed ID: 9081560
[TBL] [Abstract][Full Text] [Related]
35. Coronal reconstruction images of glucose metabolism in Alzheimer's disease.
Fukuyama H; Harada K; Yamauchi H; Miyoshi T; Yamaguchi S; Kimura J; Kameyama M; Senda M; Yonekura Y; Konishi J
J Neurol Sci; 1991 Dec; 106(2):128-34. PubMed ID: 1802960
[TBL] [Abstract][Full Text] [Related]
36. Regional cortical dysfunction in Alzheimer's disease as determined by positron emission tomography.
Chase TN; Foster NL; Fedio P; Brooks R; Mansi L; Di Chiro G
Ann Neurol; 1984; 15 Suppl():S170-4. PubMed ID: 6611118
[TBL] [Abstract][Full Text] [Related]
37. Association of premorbid intellectual function with cerebral metabolism in Alzheimer's disease: implications for the cognitive reserve hypothesis.
Alexander GE; Furey ML; Grady CL; Pietrini P; Brady DR; Mentis MJ; Schapiro MB
Am J Psychiatry; 1997 Feb; 154(2):165-72. PubMed ID: 9016263
[TBL] [Abstract][Full Text] [Related]
38. Alteration of regional cerebral glucose utilization with delusions in Alzheimer's disease.
Hirono N; Mori E; Ishii K; Kitagaki H; Sasaki M; Ikejiri Y; Imamura T; Shimomura T; Ikeda M; Yamashita H
J Neuropsychiatry Clin Neurosci; 1998; 10(4):433-9. PubMed ID: 9813789
[TBL] [Abstract][Full Text] [Related]
39. Intercorrelations of regional cerebral glucose metabolic rates in Alzheimer's disease.
Horwitz B; Grady CL; Schlageter NL; Duara R; Rapoport SI
Brain Res; 1987 Mar; 407(2):294-306. PubMed ID: 3494486
[TBL] [Abstract][Full Text] [Related]
40. Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators.
Alavi A; Newberg AB; Souder E; Berlin JA
J Nucl Med; 1993 Oct; 34(10):1681-7. PubMed ID: 8410281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
